Align Technology I (ALGN) 78.83 $ALGN Uptrend Call

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 12:28 AM

Align Technology I (ALGN) 78.83 $ALGN

Uptrend Call Working As Align Technology Stock Rises 23.7% (ALGN)
Comtex SmarTrend(R) - Thu Jun 09, 1:24AM CDT
SmarTrend identified an Uptrend for Align Technology (NASDAQ:ALGN) on February 22nd, 2016 at $64.17. In approximately 4 months, Align Technology has returned 23.69% as of today's recent price of $79.37.
ALGN: 78.83 (-0.86)

Align Technology to Speak at Upcoming Financial Conferences
Marketwired - Mon Jun 06, 11:42AM CDT
SAN JOSE, CA--(Marketwired - June 06, 2016) - Align Technology, Inc. (NASDAQ: ALGN) today announced that the company is scheduled to participate in upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the web site for approximately three months.
ALGN: 78.83 (-0.86)

Shares of ALGN Up 23.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jun 02, 1:09AM CDT
SmarTrend identified an Uptrend for Align Technology (NASDAQ:ALGN) on February 22nd, 2016 at $64.17. In approximately 3 months, Align Technology has returned 23.45% as of today's recent price of $79.22.
ALGN: 78.83 (-0.86)

Align Technology Awards Fourteen Grants Totaling $310,000 as Part of Its University Research Award Program 2016 for Orthodontic Therapy and Intraoral Scanners
Marketwire Canada - Wed Jun 01, 8:31AM CDT
SAN JOSE, CA--(Marketwired - June 01, 2016) - Align Technology, Inc. (NASDAQ: ALGN) today announced fourteen research awards totaling $310,000 in new funding to four universities in North America and eight International universities for projects seeking to better understand treatment in orthodontics, dentistry and the uses of intraoral scanners.
ALGN: 78.83 (-0.86)

Align Technology Has Returned 23.4% Since SmarTrend Recommendation (ALGN)
Comtex SmarTrend(R) - Wed May 25, 1:33PM CDT
SmarTrend identified an Uptrend for Align Technology (NASDAQ:ALGN) on February 22nd, 2016 at $64.17. In approximately 3 months, Align Technology has returned 23.44% as of today's recent price of $79.21.
ALGN: 78.83 (-0.86)

Align Technology Shares Up 18.4% Since SmarTrend's Buy Recommendation (ALGN)
Comtex SmarTrend(R) - Wed May 18, 1:23AM CDT
SmarTrend identified an Uptrend for Align Technology (NASDAQ:ALGN) on February 22nd, 2016 at $64.17. In approximately 3 months, Align Technology has returned 18.37% as of today's recent price of $75.96.
ALGN: 78.83 (-0.86)

Align Technology Rises 1.14% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon May 16, 4:17PM CDT
Align Technology (NASDAQ:ALGN) traded in a range yesterday that spanned from a low of $76.36 to a high of $77.60. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $77.18 on volume of 258,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ALGN: 78.83 (-0.86)

Align Technology to Host Analyst Meeting on June 2, 2016
Marketwire Canada - Mon May 16, 3:22PM CDT
SAN JOSE, CA--(Marketwired - May 16, 2016) - Align Technology, Inc. (NASDAQ: ALGN) announced that it will host an analyst meeting on Thursday, June 2, 2016, in New York City.
ALGN: 78.83 (-0.86)

Stuart Hockridge Joins Align Technology as Vice President of Global Human Resources
Marketwired - Mon May 09, 3:00PM CDT
SAN JOSE, CA--(Marketwired - May 09, 2016) - Align Technology, Inc. (NASDAQ: ALGN) today announced that Stuart Hockridge will join the Company on May 23, 2016 as vice president of Global Human Resources, reporting to Joe Hogan, Align Technology President and CEO.
ALGN: 78.83 (-0.86)

SmarTrend Watching for Potential Rebound in Shares of Align Technology After 2.04% Loss
Comtex SmarTrend(R) - Fri May 06, 2:43PM CDT
Align Technology (NASDAQ:ALGN) traded in a range yesterday that spanned from a low of $73.85 to a high of $75.63. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $73.97 on volume of 603,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ALGN: 78.83 (-0.86)

Becton, Dickinson (BDX) Beats Q2 Earnings on Solid Sales
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:21AM CDT
Becton, Dickinson and Company (BDX) reported second-quarter fiscal 2016 earnings of $2.18 per share, which beat the Zacks Consensus Estimate by 17 cents.
BDX: 169.29 (-0.94), BCR: 225.37 (-1.15), ALGN: 78.83 (-0.86), CNMD: 42.99 (+0.05)

Align Technology Announces $50 Million Accelerated Stock Repurchase Program and a 10b5-1 Stock Repurchase Plan
Marketwired - Wed May 04, 7:31AM CDT
SAN JOSE, CA--(Marketwired - May 04, 2016) - Align Technology, Inc. (NASDAQ: ALGN) today announced that it has entered into an accelerated stock repurchase agreement (ASR) with Morgan Stanley & Co. LLC to repurchase $50 million of Align's common stock as part of Align's $300 million stock repurchase program announced on April 23, 2014. Align previously completed the repurchase of $200 million of the program in November 2015.
ALGN: 78.83 (-0.86), MS: 25.54 (-0.54)

Henry Schein (HSIC) Tops Q1 Earnings, Keeps '16 View
Zacks Equity Research - Zacks Investment Research - Tue May 03, 12:24PM CDT
Henry Schein (HSIC) kick started 2016 on an impressive note, with its first-quarter top and bottom line beating the Zacks Consensus Estimate.
BSX: 23.02 (-0.30), ALGN: 78.83 (-0.86), BAX: 44.49 (-0.26), HSIC: 178.35 (-2.36)

Align Technology (ALGN) Beats on Q1 Earnings & Revenues
Zacks Equity Research - Zacks Investment Research - Mon May 02, 7:37AM CDT
Align Technology (ALGN) kick-started 2016 on a promising note, with its first-quarter results squarely beating the Zacks Consensus Estimate
BSX: 23.02 (-0.30), ALGN: 78.83 (-0.86), BAX: 44.49 (-0.26), OFIX: 46.16 (-1.09)

Align Technology Inc. Sees Clear Q1 Success With Invisalign Growth
Keith Speights, The Motley Fool - Motley Fool - Fri Apr 29, 10:46AM CDT
Image source: Align Technology. Shares of Align Technology have racked up nice gains of around 20% in the last 10 weeks. Continuation of that run was at stake, though, with the orthodontic-device maker announcing its first-quarter earnings...
ALGN: 78.83 (-0.86), XRAY: 63.61 (-0.82)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rain Agent Vaults: Revolutionizing Payments with AI

Innovative Payments with AI Power Alright, folks, Rain's gone and done something that's probably going to shake things up in the payments world—'cause they've given AI agents the ability to handle money like never before. We're not just talking about some run-of-the-mill integration here. This is a genuine game changer, promising to make agents as financially savvy as...

ProBio, AbTis Forge Bond for Next-Gen Oncology ADCs

Deal or No Deal: ProBio's New Licensing Agreement In the ever-evolving realm of biopharmaceuticals, ProBio's recent handshake with South Korea's AbTis is stirring the pot. The shot-callers at ProBio are passing the baton to AbTis, giving them a crack at developing a thumping new therapeutic antibody asset aimed squarely at oncology targets. Pretty slick move if you ask...

Alogent's Unify Snags Award for Innovation and Impact

Innovation That Captures Attention Alogent sure did grab the spotlight with their Unify platform walking away with a Credit Union Times Luminaries Award. The name of the game here is deposit processing innovation—the kind of buzz that turns heads in the banking world. This recognition isn't just another plaque for the lobby; it's a testament to a significant stamp on...

Sokolove Law Wins $28.8M Verdict for Misdiagnosis Case

Jury Awards $28.8 Million in Misdiagnosis Case Well, here's a tale that's bound to ruffle some feathers in the medical community—$28.8 million tossed on the table because an emergency room missed a life-threatening aortic aneurysm. For the uninitiated, this isn't just chump change; it's the cost of dropping the ball when the stakes are as high as a human life. A jury in...

FirstDigital Expands Fiber Network in Utah and Arizona

Weaving a Web of Connectivity Let's talk about FirstDigital putting its shoulder to the wheel in Utah and Arizona. They're expanding their redundant fiber network to rope in more businesses under their umbrella of connectivity. This ain't just another dry IT endeavor—it's about building a safety net for our ever-connected world. The Stakes of Network Disruption You know...

Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Alyssa Bunch: Big Moves in Tennessee Real Estate

Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...

Bakersfield Sees Spike in Crashes Post Time Change

Evening Darkness and Safety Concerns Folks, it seems Bakersfield streets transform into a battlefield once the clock falls back. With darkness creeping in earlier, those evening hours right after the time change see a sobering uptick in accidents. According to an analysis by Chain | Cohn | Clark, pedestrian and bicyclist crashes from 5 to 7 p.m. double. It's not just...

IASO Bio's In Vivo CAR-T: A Game Changer for Oncology?

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

Zephyr's Alto Hood: Redefining Kitchen Versatility

An Artist in the Kitchen Who knew a kitchen hood could be a canvas, right? Zephyr, always a punch above the ordinary in kitchen design, has pulled another rabbit out of their hat with the Alto Wall Custom Hood. Forget blending in; this piece is about standing out and shouting style—all while keeping your cooking area fresh. Options Galore The Alto Hood isn't about...